Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-10-06 | New | $159,980 | $159,980 | Debt Only | 06c | SEC link |
| 2024-11-01 | New | $720,000 | $720,000 | Equity Only | 06c | SEC link |
| 2023-04-25 | New | $25,000 | $25,000 | Other | 06c | SEC link |
| 2022-03-30 | New | $445,000 | $445,000 | Equity Only | 06b | SEC link |
| 2021-03-18 | New | $470,000 | $470,000 | Debt Only | 06b | SEC link |
| Name | Role |
|---|---|
| Steven J. Daly | Director |
| Steven Daly, M.S., M.B.A. | Director |
| Andrew J Holman | Director, Executive |
| Andrew Holman, M.D. | Director, Executive |
| Leroy Hood, M.D., Ph.D. | Director |
| Ryan Sullivan, Ph.D. | Director |
| Bernie Tobin | Director |
| Kevin Tracey, M.D. | Director |